Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.

Sergio Sauri-SuárezSandra Quiñones-AguilarArturo Contreras-MarínErik Omar Ramiro-GuerreroDavid Zúñiga-GarcíaLeticia Salinas-VázquezLeonardo Llamas-LópezCarolina León-JiménezAdriana García-MartellIliana González-HernándezErwin ChiqueteSilvia Garcia

Published in: PloS one (2020)

Adherence to INF-β1a using RebiSmart® in this Mexican cohort with MS was moderate, but associated with low relapse rate and influenced by high schooling.

Keyphrases

multiple sclerosis
white matter

dendritic cells
glycemic control

high intensity
mass spectrometry

ms ms
rheumatoid arthritis